Login    Join free Add to favorites    中文
home > news > Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

hits:1848     Date:12/24/14

       •  Expiration of waiting period completing the US antitrust review process for the two companies 
       •  Merck continues to expect the transaction to close in mid-2015
 
Darmstadt, Germany, December 23, 2014 鈥 Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, today announced that it has obtained antitrust clearance from the United States Federal Trade Commission (FTC) for its planned acquisition of US-based life science company Sigma-Aldrich.
 
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with its proposed acquisition of Sigma-Aldrich Corporation expired on December 22, 2014, thereby completing the US HSR Act antitrust notification and review requirement for the two companies. 

Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

US antitrust clearance satisfies a condition to closing the transaction, which remains subject to certain other closing conditions, including regulatory approval in other jurisdictions. Sigma-Aldrich shareholders have already approved the acquisition at a special meeting in St. Louis, Missouri, USA on December 5, 2014. Merck continues to expect the transaction to close in mid-2015.
 
On September 22, 2014, Merck and Sigma-Aldrich announced that they had entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (鈧13.1 billion), establishing one of the leading players in the $130 billion global life science industry. The acquisition is a key element in Merck鈥檚 鈥淔it for 2018鈥 transformation and growth program aimed at strengthening the company鈥檚 three growth platforms, healthcare, life science and performance materials.
 
The combined company would be able to serve life science customers around the world with a highly attractive set of established brands and an efficient supply chain that can support the delivery of more than 300,000 products. In the Laboratory & Academia business, together Merck Millipore and Sigma-Aldrich would offer their customers a complementary range of products across laboratory chemicals, biologics and reagents. In pharma and biopharma production, Sigma-Aldrich would complement Merck Millipore鈥檚 existing products and capabilities with additions along the entire value chain of drug production and validation.

Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt
Hotline +49 6151 72-5000
 
Head Media Relations -62445
Fax +49 6151 72-3138
Spokesperson: -9591 / -7144 / -6328
Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙